Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) face significant survival disparities and ...

Researchers sought to determine whether the ALL-Hematotox would be able to predict hematotoxicity for patients with B-ALL who are at risk of severe hematotoxicity following CAR-T therapy.

B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

Two years ago, we introduced you to Tobias and his mother, Charity DeLeon—a brave family thrust into a battle they never ...

The autologous immunotherapy consists of the patient’s own T cells engineered to express a chimeric antigen receptor that ...

The Fonda Fultonville School District is mourning the loss of a middle school student who died earlier this week.

Positive CHMP opinion based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicityOpinion follows ...

June 1 marks the final day of Sawyer Wobig’s treatment for B Cell Acute Lymphoblastic Leukemia. Sawyer, age 9, lives in ...

Autolus Therapeutics (AUTL) stock in focus as the company wins EU panel's endorsement for leukemia therapy. Read more here.